Schizophrenia bulletin
Journal
Overview
publication venue for
-
Dimensions of Schizophrenia Spectrum Symptomatology and Time Perception: a Systematic Review.
2025
-
Peripheral Microvascular and Cerebral White Matter Dysfunction in Schizophrenia: Implications of a Body-Brain Endothelial Pathophysiology..
51.
2025
-
Revisiting the Defeatist Performance Belief Scale in Adults With Schizophrenia and Youth at Clinical High-Risk for Psychosis: A Comprehensive Psychometric Analysis..
51.
2025
-
Evidence of Neurovascular Water Exchange and Endothelial Vascular Dysfunction in Schizophrenia: An Exploratory Study..
49.
2023
-
Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE Study..
49.
2023
-
Differential Effects of Clozapine and Haloperidol on the 40 Hz Auditory Steady State Response-mediated Phase Resetting in the Prefrontal Cortex of the Female Sprague Dawley Rat..
49.
2023
-
Two Factors, Five Factors, or Both? External Validation Studies of Negative Symptom Dimensions in Schizophrenia..
48.
2022
-
N-methyl-D-aspartate Receptor Antibody and White Matter Deficits in Schizophrenia Treatment-Resistance..
47.
2021
-
Allostatic Load Effects on Cortical and Cognitive Deficits in Essentially Normotensive, Normoweight Patients with Schizophrenia..
47.
2021
-
The Latent Structure of Negative Symptoms in Individuals With Attenuated Psychosis Syndrome and Early Psychosis: Support for the 5 Consensus Domains..
47.
2021
-
A White Matter Connection of Schizophrenia and Alzheimer's Disease..
47.
2021
-
Neurophysiological, Oculomotor, and Computational Modeling of Impaired Reading Ability in Schizophrenia..
47.
2021
-
Choroid Plexus Enlargement and Allostatic Load in Schizophrenia..
46.
2020
-
Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia..
45.
2019
-
White Matter Abnormalities Associated With Subsyndromal Psychotic-Like Symptoms Predict Later Social Competence in Children and Adolescents..
43.
2016
-
A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes..
41.
2015
-
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia..
42.
2015
-
Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention..
41.
2015
-
Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models..
41.
2014
-
Schizophrenia--time to commit to policy change..
40 Suppl 3.
2014
-
Guideline-concordant antipsychotic use and mortality in schizophrenia..
39.
2012
-
Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia..
39.
2011
-
Attention shaping: a reward-based learning method to enhance skills training outcomes in schizophrenia..
35.
2008
-
Various bilateral olfactory deficits in male patients with schizophrenia..
31.
2005
-
Investigating graphesthesia task performance in the biological relatives of schizophrenia patients..
30.
2004
-
Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines..
28.
2002
-
Genetic and state variables of neurocognitive dysfunction in schizophrenia: a twin study..
26.
2000
-
Schizophrenia in late life: elderly patients admitted to an acute care psychiatric hospital..
19.
1993
-
Examining the underlying structure of schizophrenic phenomenology: evidence for a three-process model..
17.
1991
-
Gender and schizophrenia outcome: a clinical trial of an inpatient family intervention..
16.
1990
-
Platelet monoamine oxidase activity in subgroups of schizophrenic disorders..
6.
1980
-
Two reviews of the literature on borderlines: an assessment..
5.
1979
-
A Recessively Inherited Risk Locus on Chromosome 13q22-31 Conferring Susceptibility to Schizophrenia..
47.
2021
-
Schizotypy, Schizotypic Psychopathology, and Schizophrenia: Hearing Echoes, Leveraging Prior Advances, and Probing New Angles..
44.
2018
-
Thinking clearly about schizotypy: hewing to the schizophrenia liability core, considering interesting tangents, and avoiding conceptual quicksand..
41 Suppl 2.
2015
-
Reconsidering the Latent Structure of Negative Symptoms in Schizophrenia: A Review of Evidence Supporting the 5 Consensus Domains.
2019
-
Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.
2016
-
Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.
2015
-
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics.
2015
-
The promise of biological markers for treatment response in first-episode psychosis: a systematic review.
2015
-
Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis.
2014
-
Current issues in the classification of psychotic major depression.
2007
-
Cognitive remediation in schizophrenia: should we attempt it?
1992
contributor
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)